Q-Linea
2.18 SEK -0.91%Be the first to follow this company
Q-Linea is active in medical technology. The company specializes in the research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning and include diagnostic and analysis tools, as well as other related basic sample handlings. The technology is based on the so-called ID and AST technology. The company was founded in 2008 and is headquartered in Uppsala.
Revenue
4.44M
EBIT %
-5,193.47 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
QLINEA
Daily low / high price
2.155 / 2.24
SEK
Market cap
255.42M SEK
Turnover
221.06K SEK
Volume
101K
Latest videos
Financial calendar
Interim report
2024-05-28
General meeting
2024-06-28
Interim report
2024-07-11
Interim report
2024-10-31
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Nexttobe AB | 53.5 % | 53.5 % |
Fjärde AP-fonden | 8.0 % | 8.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Ändrade datum för kvartalsrapport och årsstämma
Changed dates for Interim Report and Annual General Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools